Management of Prerenal Acute Kidney Injury

Initial Management

The American College of Physicians recommends immediate withdrawal of all nephrotoxic medications, including NSAIDs, ACE inhibitors, ARBs, aminoglycosides, and contrast agents, as these worsen kidney injury regardless of etiology 1, 2
The National Kidney Foundation suggests careful volume assessment to determine if fluid resuscitation is appropriate, and recognition that the BUN:Cr ratio alone is an unreliable marker for distinguishing prerenal from intrinsic kidney injury 1, 2

The American Society of Nephrology recommends immediately discontinuing all nephrotoxic agents, including NSAIDs, ACE inhibitors, ARBs, aminoglycosides, and contrast agents, as these worsen kidney injury regardless of etiology 1, 2
The European Renal Association suggests withdrawing or reducing diuretics, as they falsely elevate fractional excretion of sodium (FENa) and can perpetuate volume depletion 3, 1

The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend determining if the patient has true hypovolemia or volume overload, as indiscriminate fluid administration worsens outcomes 2
The American College of Cardiology suggests that a clear temporal relationship between volume depletion and AKI onset, clinical signs of hypovolemia, recent significant blood loss, and absence of volume overload signs are indications for fluid challenge 1, 2, 3

The European Society of Intensive Care Medicine recommends using balanced crystalloids (lactated Ringer's) as first-line therapy, 500-1000 mL over 30-60 minutes 2
The American Society of Nephrology suggests avoiding 0.9% saline, which causes metabolic acidosis and hyperchloremia, and never using hydroxyethyl starches, which increase mortality and worsen AKI 2

The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend urine microscopy in all AKI cases, as it can help distinguish between prerenal and intrinsic AKI 5, 2
The American Association for the Study of Liver Diseases suggests that a fractional excretion of urea (FEUrea) <28% has better discrimination for hepatorenal syndrome versus non-HRS causes, and is not affected by diuretics 3, 4

The National Kidney Foundation recommends measuring serum creatinine every 2-4 days during hospitalization to assess AKI progression 5, 1, 6
The American College of Physicians suggests monitoring daily for electrolyte abnormalities, particularly potassium >6.0 mEq/L, which represents the most immediately life-threatening complication requiring urgent treatment 1

The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend that even if AKI fully "recovers," patients remain at significantly increased long-term risk of recurrent AKI, progression to chronic kidney disease, cardiovascular events, and increased mortality 1, 2
The American Society of Nephrology suggests mandatory follow-up includes creatinine checks every 2-4 weeks for 6 months post-discharge, with nephrology referral if creatinine fails to return to within 115% of baseline 1, 2